Catheter Precision, Inc.

10 articles with Catheter Precision, Inc.

• Ra Medical Systems Realigns Its Board of Directors

  1/17/2023

  Ra Medical Systems (NYSE American: RMED) announces a realignment of its board of directors in conjunction with the recently announced merger with Catheter Precision, Inc. David Jenkins has joined the board as Executive Chairman and James Caruso has been named director.

• Ra Medical Systems Completes Merger with Catheter Precision

  1/10/2023

  Ra Medical Systems, Inc. (NYSE American: RMED) (“Ra Medical” or the “Company”) announces the completion of its previously announced stock-for-stock merger transaction with Catheter Precision, Inc., a company focused on the cardiac electrophysiology market.

• Catheter Precision’s VIVO™ System Used in More Than 800 Procedures in Leading U.S. and European Hospitals

  12/1/2022

  Catheter Precision, Inc. announces that more than 800 procedures have been performed in a number of leading U.S. and European hospitals utilizing the VIVO System that enables physicians to noninvasively identify an area of ventricular arrhythmia onset.

• Catheter Precision’s VIVO™ Systems Used in More Than 20 Procedures at NYU Langone Hospital

  11/29/2022

  Catheter Precision, Inc. announces the completion of more than 20 procedures at NYU Langone Hospital utilizing the VIVO System that enables physicians to identify the origin of arrhythmias pre-procedure.

• Catheter Precision Expands U.S. Customer Base for VIVO™ for Non-invasive Arrythmia Location Detection Before Ventricular Ablation Procedures

  10/20/2022

  Catheter Precision, Inc. (“Catheter Precision”), a medical device company focused on cardiac electrophysiology, announces receipt of three commercial orders in the past 60 days as usage of the device continues to increase in the U.S.

• Catheter Precision Files a Method-of-Use U.S. Patent Application for its VIVO™ Technology

  10/4/2022

  Catheter Precision, Inc., a medical device company focused on cardiac electrophysiology, announces the filing of a new U.S. patent application for its VIVO™ technology, as it continues its focus on patent protection for VIVO.

• Catheter Precision’s VIVO™ Technology to be Featured in Three Presentations at the Global Society of Cardiac Robotic Navigation Annual Meeting

  9/29/2022

  Catheter Precision, Inc., a medical device and technology company focused on cardiac electrophysiology, announces that its lead product, VIVO™ (View Into Ventricular Onset), will be featured in presentations by three physicians working in the field of cardiac electrophysiology at the Sixth Annual Society of Cardiac Robotic Navigation (SCRN) meeting being held September 29-30 in Budapest, Hungary.

• Catheter Precision Names Fatih Ayoglu as Business Development Manager—EMEA

  9/27/2022

  Catheter Precision, Inc., a medical device and technology company focused on cardiac electrophysiology, announces the appointment of Fatih Ayoglu to the newly created position of Business Development Manager—EMEA.

• Ra Medical Systems Enters Into Definitive Merger Agreement with Catheter Precision

  9/12/2022

  Ra Medical Systems, Inc. (NYSE American: RMED) (“Ra Medical” or the “Company”) announces it has entered into an Agreement and Plan of Merger (the “Definitive Merger Agreement”) with privately held Catheter Precision, Inc. (“Catheter Precision”), a medical device and technology company focused in the field of cardiac electrophysiology.

• Catheter Precision Launches Clinical Trial for Its VIVO™ Non-Invasive Mapping System

  2/20/2018

  Study Expected to Expand to Five Hospitals and Evaluate Accuracy of the VIVO System.